Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07583823 · ClinicalTrials.gov registry record · NA
Elevated Rate Pacing of Cardiac Amyloidosis
A NA study, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07583823 is a NA study that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 10 participants.
The verdict
NCT07583823, a NA study, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.
Interventions
- OTHER Pacemaker Rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-10 |
| Est. Completion | 2026-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07583823
The ClinicalTrials.gov registry entry for NCT07583823 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pacemaker Rate is the first listed.
NCT07583823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07583823 about?
NCT07583823 is a clinical study titled "Elevated Rate Pacing of Cardiac Amyloidosis". This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.
What is the current status of trial NCT07583823?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-10. Estimated completion is 2026-10-10.
What interventions are being tested in trial NCT07583823?
The interventions under investigation include: Pacemaker Rate (OTHER).
Who is sponsoring clinical trial NCT07583823?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.